Current Neuro-Oncology
Volume
23 Number 2
31 January 2021
Home > Publications > Current Neuro-Oncology > Volume 23, Year 2021 > Number 2, 31 January
Dutz
A, Lühr A, Agolli L, Bütof R, Valentini C, Troost EGC,
Baumann M, Vermeren X, Geismar D, Lamba N, Lebow ES, Bussière
M, Daly JE, Bussière MR, Krause M, Timmermann B, Shih HA,
Löck S.
Modelling
of late side-effects following cranial proton beam
therapy.
Radiother
Oncol. 2021 Jan 18;157:15-23∟.
doi: 10.1016/j.radonc.2021.01.004∟.
PMID: 33482232∟.
Observational study. ˍ
Massimino
M, Signoroni S, Boschetti L, Chiapparini L, Erbetta A, Biassoni V,
Schiavello E, Ferrari A, Spreafico F, Terenziani M, Chiaravalli S,
Puma N, Bergamaschi L, Ricci MT, Cattaneo L, Gattuso G, Buttarelli
FR, Gianno F, Miele E, Poggi G, Vitellaro M.
Medulloblastoma
and familial adenomatous polyposis: Good prognosis and good
quality of life in the long-term?
Pediatr
Blood Cancer. 2021 Jan 18;68(4):e28912∟.
doi: 10.1002/pbc.28912∟.
PMID: 33459525∟.
Observational study. ˍ
*
Nagai
Yamaki V, de Souza Godoy LF, Alencar Bandeira G, Tavares Lucato L,
Correa Lordelo G, Fontoura Solla DJ, Santana Neville I, Jacobsen
Teixeira M, Silva Paiva W.
Dural-based
lesions: is it a meningioma?
Neuroradiology.
2021 Jan 18∟.
doi: 10.1007/s00234-021-02632-y∟.
PMID: 33459822∟.
Observational study. ˍ
*
Aldaz
P, Auzmendi-Iriarte J, Durántez M, Lasheras-Otero I,
Carrasco-Garcia E, Zelaya MV, Bragado L, Olías-Arjona A,
Egaña L, Samprón N, Morilla I, Redondo-Muñoz
M, Rico M, Squatrito M, Maria-Alonso M, Fernández-Irigoyen
J, Santamaria E, Larráyoz IM, Wellbrock C, Matheu A,
Arozarena I.
Identification
of a Dexamethasone Mediated Radioprotection Mechanism Reveals New
Therapeutic Vulnerabilities in Glioblastoma.
Cancers
(Basel). 2021 Jan 19;13(2):361∟.
doi: 10.3390/cancers13020361∟.
PMID: 33478100∟.
Laboratory investigation. ˍ
Reis
J, Stahl R, Zimmermann H, Ruf V, Thon N, Kunz M, Liebig T, Forbrig
R.
Advanced
MRI Findings in Medulloblastomas: Relationship to Genetic
Subtypes, Histopathology, and Immunohistochemistry.
J
Neuroimaging. 2021 Jan 19;31(2):306-316∟.
doi: 10.1111/jon.12831∟.
PMID: 33465267∟.
Observational study. ˍ
Shepard
MJ, Xu Z, Kearns K, Li C, Chatrath A, Sheehan K, Sheehan D,
Faramand A, Niranjan A, Kano H, Gurewitz J, Bernstein K, Liscak R,
Guseynova K, Grills IS, Parzen JS, Cifarelli CP, Rehman AA, Atik
A, Bakhsheshian J, Zada G, Chang E, Giannotta S, Speckter H, Wu
HM, Kondziolka D, Golfinos JG, Mathieu D, Lee CC, Warnick RE,
Lunsford LD, Sheehan JP.
Stereotactic
Radiosurgery for Atypical (World Health Organization II) and
Anaplastic (World Health Organization III) Meningiomas: Results
From a Multicenter, International Cohort Study.
Neurosurgery.
2021 Jan 19;88(5):980-988∟.
doi: 10.1093/neuros/nyaa553∟.
PMID: 33469655∟.
Observational study. ˍ
Bunevicius
A, Anand RK, Suleiman M, Nabeel AM, Reda WA, Tawadros SR,
Abdelkarim K, El-Shehaby AMN, Emad RM, Chytka T, Liscak R, Sheehan
K, Sheehan D, Caceres MP, Mathieu D, Lee CC, Yang HC, Picozzi P,
Franzini A, Attuati L, Speckter H, Olivo J, Patel S, Cifarelli CP,
Cifarelli DT, Hack JD, Strickland BA, Zada G, Chang EL, Fakhoury
KR, Rusthoven CG, Warnick RE, Sheehan J.
Stereotactic
Radiosurgery for Perioptic Meningiomas: An International,
Multicenter Study.
Neurosurgery.
2021 Jan 20;88(4):828-837∟.
doi: 10.1093/neuros/nyaa544∟.
PMID: 33475718∟.
Observational study. ˍ
Divé
I, Steidl E, Wagner M, Filipski K, Burger MC, Franz K, Harter PN,
Bähr O, Fokas E, Herrlinger U, Steinbach JP.
Gliomatosis
Cerebri Growth Pattern: Association of Differential First-Line
Treatment with Overall Survival in WHO Grade II and III
Gliomas.
Oncology.
2021 Jan 20;99(4):215-224∟.
doi: 10.1159/000512562∟.
PMID: 33472203∟.
Observational study. ˍ
Joubert
C, Sellier A, Sahuc P, Beucler N, Desse N, Bernard C, Cungi PJ,
Dagain A.
Neurosurgery
for intracranial meningioma in patients aged more than 80 years:
benefits and rationale.
Br
J Neurosurg. 2021 Jan 20:1-6∟.
doi: 10.1080/02688697.2021.1875397∟.
PMID: 33470146∟.
Observational study. ˍ
Mascarenhas
L, Ogawa C, Laetsch TW, Weigel BJ, Bishop MW, Krystal J,
Borinstein SC, Slotkin EK, Muscal JA, Hingorani P, Levy DE, Mo G,
Shahir A, Wright J, DuBois SG.
Phase
1 trial of olaratumab monotherapy and in combination with
chemotherapy in pediatric patients with relapsed/refractory solid
and central nervous system tumors.
Cancer
Med. 2021 Jan 20;10(3):843-856∟.
doi: 10.1002/cam4.3658∟.
PMID: 33474828∟.
Interventional study. ˍ
Wang
H, Mejia MC, Gonzalez SJ, Zoorob RJ, Chai W, Du XL.
Cancer
incidence and survival trends among infants in the United States
from 1975 to 2014.
Pediatr
Blood Cancer. 2021 Jan 20;68(4):e28917∟.
doi: 10.1002/pbc.28917∟.
PMID: 33470510∟.
Observational
study. ˍ
*
Berg
TJ, Marques C, Pantazopoulou V, Johansson E, von Stedingk K,
Lindgren D, Jeannot P, Pietras EJ, Bergström T, Swartling FJ,
Governa V, Bengzon J, Belting M, Axelson H, Squatrito M, Pietras
A.
The
irradiated brain microenvironment supports glioma stemness and
survival via astrocyte-derived Transglutaminase 2.
Cancer
Res. 2021 Jan 22:canres.1785.2020∟.
doi: 10.1158/0008-5472.CAN-20-1785∟.
PMID: 33483373∟.
Laboratory investigation. ˍ
*
Patrizz
A, Dono A, Zhu P, Tandon N, Ballester LY, Esquenazi Y.
Tumor
recurrence or treatment-related changes following chemoradiation
in patients with glioblastoma: does pathology predict outcomes?
J
Neurooncol. 2021 Jan 22;152(1):163-172∟.
doi: 10.1007/s11060-020-03690-7∟.
PMID: 33481149∟.
Observational study. ˍ
Baumgarten
P, Sarlak M, Monden D, Spyrantis A, Bernatz S, Gessler F, Dubinski
D, Hattingen E, Marquardt G, Strzelczyk A, Rosenow F, Harter PN,
Seifert V, Freiman TM.
Early
and Late Postoperative Seizures in Meningioma Patients and
Prediction by a Recent Scoring System.
Cancers
(Basel). 2021 Jan 25;13(3):450∟.
doi: 10.3390/cancers13030450∟.
PMID: 33504023∟.
Observational study. ˍ
Xiao
X, Liu X, Liang W, Han LY, Li XD, Guo LJ, He WL, Liu XM, Zhou J,
Cai Q, Xu YK, Tan XL, Wu YK.
Conventional
MRI Features of Central Nervous System Embryonal Tumor, Not
Otherwise Specified in Adults: Comparison with Glioblastoma.
Acad
Radiol. 2021 Jan 25:S1076-6332(21)00019-2∟.
doi: 10.1016/j.acra.2021.01.010∟.
PMID: 33504445∟.
Observational study. ˍ
Andrews
DW, Judy KD, Scott CB, Garcia S, Harshyne LA, Kenyon L, Talekar K,
Flanders A, Atsina KB, Kim L, Martinez N, Shi W, Werner-Wasik M,
Liu H, Prosniak M, Curtis M, Kean R, Ye DY, Bongiorno E, Sauma S,
Exley MA, Pigott K, Hooper DC.
Phase
Ib Clinical Trial of IGV-001 for Patients with Newly Diagnosed
Glioblastoma.
Clin
Cancer Res. 2021 Jan 26;27(7):1912-1922∟.
doi: 10.1158/1078-0432.CCR-20-3805∟.
PMID: 33500356∟.
Interventional study. ˍ
Reardon
DA, Kim TM, Frenel JS, Simonelli M, Lopez J, Subramaniam DS, Siu
LL, Wang H, Krishnan S, Stein K, Massard C.
Treatment
with pembrolizumab in programmed death ligand 1-positive recurrent
glioblastoma: Results from the multicohort phase 1 KEYNOTE-028
trial.
Cancer.
2021 Jan 26∟.
doi: 10.1002/cncr.33378∟.
PMID: 33496357∟.
Interventional study. ˍ
Brenner
AJ, Floyd J, Fichtel L, Michalek J, Kanakia KP, Huang S, Reardon
D, Wen PY, Lee EQ.
Phase
2 trial of hypoxia activated evofosfamide (TH302) for treatment of
recurrent bevacizumab-refractory glioblastoma.
Sci
Rep. 2021 Jan 27;11(1):2306∟.
doi: 10.1038/s41598-021-81841-0∟.
PMID: 33504881∟.
Interventional study. ˍ
Momin
AA, Recinos MA, Cioffi G, Patil N, Soni P, Almeida JP, Kruchko C,
Barnholtz-Sloan JS, Recinos PF, Kshettry VR.
Descriptive
epidemiology of craniopharyngiomas in the United
States.
Pituitary.
2021 Jan 28∟.
doi: 10.1007/s11102-021-01127-6∟.
PMID: 33506438∟.
Observational study. ˍ
Park
CJ, Han K, Kim H, Ahn SS, Choi D, Park YW, Chang JH, Kim SH, Cha
S, Lee SK.
MRI
Features May Predict Molecular Features of Glioblastoma in
Isocitrate
Dehydrogenase
Wild-Type
Lower-Grade Gliomas.
AJNR
Am J Neuroradiol. 2021 Jan 28;42(3):448-456∟.
doi: 10.3174/ajnr.A6983∟.
PMID: 33509914∟.
Observational study. ˍ
Ruge
MI, Tutunji J, Rueß D, Celik E, Baues C, Treuer H, Kocher M,
Grau S.
Stereotactic
radiosurgery for treating meningiomas eligible for complete
resection.
Radiat
Oncol. 2021 Jan 28;16(1):22∟.
doi: 10.1186/s13014-021-01748-y∟.
PMID: 33509211∟.
Observational study. ˍ
Zhang
Y, Cai J, Lin Z, Yao S, Miao W.
Primary
Central Nervous System Lymphoma Revealed by 68Ga-FAPI and 18F-FDG
PET/CT.
Clin
Nucl Med. 2021 Jan 28∟.
doi: 10.1097/RLU.0000000000003517∟.
PMID: 33512949∟.
Case report˰ ˍ
Bashiri
FA, AlZamil LR, Aldhuwayhi RA.
Clinical
spectrum of neurofibromatosis type 1 among children in a tertiary
care center.
Neurosciences
(Riyadh). 2021 Jan 30, 2020;25(5):375-379∟.
doi: 10.17712/nsj.2020.5.20200081∟.
PMID: 33459286∟.
Observational study. ˍ
Wefel
JS, Armstrong TS, Pugh SL, Gilbert MR, Wendland MM, Brachman DG,
Roof KS, Brown PD, Crocker IR, Robins HI, Hunter G, Won M, Mehta
MP.
Neurocognitive,
Symptom, and Health- Related Quality of Life Outcomes of a
Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
(NRG/RTOG 0825).
Neuro
Oncol. 2021 Jan 30:noab011∟.
doi: 10.1093/neuonc/noab011∟.
PMID: 33515019∟.
Interventional study. ˍ